nafamostat has been researched along with Extravasation of Contrast Media in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dose-response curve of tryptase action was bell-shaped and the effect peaked at 0." | 1.33 | Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. ( Andoh, T; Kuraishi, Y; Lee, JB; Nojima, H; Ui, H, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ui, H | 1 |
| Andoh, T | 1 |
| Lee, JB | 1 |
| Nojima, H | 1 |
| Kuraishi, Y | 1 |
1 other study available for nafamostat and Extravasation of Contrast Media
| Article | Year |
|---|---|
Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice.
Topics: Animals; Antibodies; Antipruritics; Benzamidines; Dose-Response Relationship, Drug; Extravasation of | 2006 |